PMC Articles for MedGen (Select 107497) - PMC

Result Filters

Links from MedGen

Items: 1 to 20 of 191

<< First< Prev

Page of 10

Select item 111895051.

Evaluation of the impact of systemic dexamethasone dosage on docetaxel-induced hand-foot syndrome in patients with breast cancer

Yoshitaka Saito, Yoh Takekuma, Masato Takahashi, Tomohiro Oshino, Mitsuru Sugawara

Sci Rep. 2024; 14: 14083. Published online 2024 Jun 18. doi: 10.1038/s41598-024-64553-z

PMCID:: PMC11189505

Abstract Article PDF–1.1M

Select item 110937912.

Hand-foot syndrome in cancer patients on capecitabine: examining prevalence, impacts, and associated risk factors at a cancer centre in Malaysia

Teck Long King, Pei Jye Voon, Kah Hay Yuen, Dzul Azri Mohamed Noor

Support Care Cancer. 2024; 32(6): 345. Published online 2024 May 14. doi: 10.1007/s00520-024-08490-7

PMCID:: PMC11093791

Abstract Article PDF–613K

Select item 110690373.

Capecitabine-Induced Genital Hand-Foot Syndrome Treated With Topical Tacrolimus

Bryan L Chan, Tina Wang

Cureus. 2024 Apr; 16(4): e57570. Published online 2024 Apr 3. doi: 10.7759/cureus.57570

PMCID:: PMC11069037

Abstract Article PDF–605K

Select item 107833584.

Predictive factors for the development of capecitabine-induced hand-foot syndrome: a retrospective observational cohort study

Chaichana Chantharakhit, Nantapa Sujaritvanichpong

Ann Med Surg (Lond) 2024 Jan; 86(1): 73–77. Published online 2023 Nov 7. doi: 10.1097/MS9.0000000000001487

PMCID:: PMC10783358

Abstract Article PDF–343K

Select item 106422915.

Topical interventions for preventing hand-foot syndrome resulting from antineoplastic therapy: A scoping review

Fernanda Cristina Gialaim Purcino dos Reis, Amanda Gomes de Menêses, Simone Roque Mazoni, Renata Cristina de Campos Pereira Silveira, Paula Elaine Diniz dos Reis, Christiane Inocêncio Vasques

Rev Esc Enferm USP. 2023; 57: e20220107. Published online 2023 Nov 10. doi: 10.1590/1980-220X-REEUSP-2023-0107en

PMCID:: PMC10642291

Abstract Article PDF–1.0M

Select item 104084876.

Calcium dobesilate prevents PLD-induced hand-foot syndrome by alleviating capillary endothelial tight junction injury via the HA/CD44 pathway

Chao Li, Bin Xu, Heng Song, Yu Xu, Ling-Zi Shi, Xiao-Qing Chen, Zhen-Chuan Song

Am J Cancer Res. 2023; 13(7): 3234–3245. Published online 2023 Jul 15.

PMCID:: PMC10408487

Abstract Article PDF–1.8M

Select item 104048837.

DNA damage-mediated cellular senescence promotes hand-foot syndrome that can be relieved by thymidine prodrug

Bingxue Yang, Xinran Xie, Zhaoyu Wu, Dazhao Lv, Jiajun Hu, Yuyun Chen, Jiaxing Li, Shuyue Luo, Jiacheng Li, Jie Luo, Shiyi Zhang

Genes Dis. 2023 Nov; 10(6): 2557–2571. Published online 2022 Oct 18. doi: 10.1016/j.gendis.2022.10.004

PMCID:: PMC10404883

Abstract Article PDF–4.7M

Select item 101730708.

Capecitabine-induced oral mucosal hyperpigmentation associated with hand-foot syndrome – A literature review

Anna Danielly Almeida do Nascimento, Débora Maria Porto, Aurora Karla de Lacerda Vidal

An Bras Dermatol. 2023 May-Jun; 98(3): 302–309. Published online 2023 Feb 17. doi: 10.1016/j.abd.2022.05.004

PMCID:: PMC10173070

Abstract Article PDF–2.0M

Select item 101631539.

Fluoropyrimidine-induced hand-foot syndrome and cardiotoxicity: recommendations for the use of the oral fluoropyrimidine S-1 in metastatic colorectal cancer

C.J.A. Punt, V. Heinemann, T. Maughan, C. Cremolini, E. Van Cutsem, R. McDermott, G. Bodoky, T. André, P. Osterlund, A.J. Teske, P. Pfeiffer

ESMO Open. 2023 Apr; 8(2): 101199. Published online 2023 Apr 3. doi: 10.1016/j.esmoop.2023.101199

PMCID:: PMC10163153

Abstract Article PDF–463K

Select item 1011573010.

Efficacy of regional cooling + oral dexamethasone for primary prevention of hand-foot syndrome associated with pegylated liposomal doxorubicin

Katsuhiko Nara, Ayumi Taguchi, Takehito Yamamoto, Tetsushi Tsuruga, Yuri Tojima, Yuichiro Miyamoto, Michihiro Tanikawa, Kenbun Sone, Mayuyo Mori, Tappei Takada, Hiroshi Suzuki, Yutaka Osuga

Support Care Cancer. 2023; 31(5): 283. Published online 2023 Apr 19. doi: 10.1007/s00520-023-07718-2

PMCID:: PMC10115730

Abstract Article PDF–631K

Select item 990248511.

Capecitabine induces hand-foot syndrome through elevated thymidine phosphorylase-mediated locoregional toxicity and GSDME-driven pyroptosis that can be relieved by tipiracil

Bingxue Yang, Xinran Xie, Dazhao Lv, Jiajun Hu, Yuyun Chen, Zhaoyu Wu, Shuyue Luo, Shiyi Zhang

Br J Cancer. 2023 Jan 19; 128(2): 219–231. Published online 2022 Nov 8. doi: 10.1038/s41416-022-02039-3

PMCID:: PMC9902485

Abstract Article PDF–5.1M

Select item 975115412.

Pyridoxine Is Effective for Preventing Hand-Foot Syndrome Induced by Pegylated Liposomal Doxorubicin for Multiple Myeloma: The Results of a Randomized Study

Li Xiaozhe, Chen Meilan, Huang Beihui, Liu Junru, Gu Jingli, Kuang Lifen, Li Juan

Integr Cancer Ther. 2022; 21: 15347354221140402. Published online 2022 Dec 12. doi: 10.1177/15347354221140402

PMCID:: PMC9751154

Abstract Article PDF–613K

Select item 964518713.

Oral hyperpigmentation as an initial clinical aspect of hand foot syndrome

Éder Gerardo dos Santos-Leite, Lorena Vieira Sacramento, Alessandra Monteiro Santana, Juliana Borges de Lima Dantas, Manoela Carrera, Gabriela Botelho Martins

Braz Dent J. 2022 Jul-Aug; 33(4): 97–102. Published online 2022 Aug 26. doi: 10.1590/0103-6440202204711

PMCID:: PMC9645187

Abstract Article PDF–307K

Select item 954560914.

Genetic variation in ST6GAL1 is a determinant of capecitabine and oxaliplatin induced hand‐foot syndrome

Katie Watts, Christopher Wills, Ayman Madi, Claire Palles, Timothy S. Maughan, Richard Kaplan, Nada A. Al‐Tassan, Rachel Kerr, David J. Kerr, Richard S. Houlston, Valentina Escott‐Price, Jeremy P. Cheadle

Int J Cancer. 2022 Sep 15; 151(6): 957–966. Published online 2022 May 10. doi: 10.1002/ijc.34046

PMCID:: PMC9545609

Abstract Article PDF–3.8M

Select item 939669015.

Hand–foot syndrome induced by chemotherapy drug: Case series study and literature review

Ahmed Zaiem, Syrine Ben Hammamia, Imen Aouinti, Ons Charfi, Walid Ladhari, Sarrah Kastalli, Sihem El Aidli, Ghozlane Lakhoua

Indian J Pharmacol. 2022 May-Jun; 54(3): 208–215. Published online 2022 Jul 12. doi: 10.4103/ijp.ijp_175_21

PMCID:: PMC9396690

Abstract Article

Select item 937583716.

Hand-Foot Syndrome Presentation Post-Capecitabine Treatment in a Black Patient

Allison E Whorton, Abrahim N Razzak, Pinky Jha

Cureus. 2022 Jul; 14(7): e26891. Published online 2022 Jul 15. doi: 10.7759/cureus.26891

PMCID:: PMC9375837

Abstract Article PDF–804K

Select item 930039917.

Hand-foot syndrome caused by capecitabine: incidence, risk factors and the role of dermatological evaluation

Marina Vieira Rodrigues de Queiroz, Ana Carolina Tardin Rodrigues de Medeiros, Sarah Pires Toledo, Karina Demoner de Abreu Sarmenghi, Vitor Fiorin de Vasconcellos

Ecancermedicalscience. 2022; 16: 1390. Published online 2022 May 16. doi: 10.3332/ecancer.2022.1390

PMCID:: PMC9300399

Abstract Article PDF–199K

Select item 928476918.

Study protocol of a single-arm phase 2 study evaluating the preventive effect of topical hydrocortisone for capecitabine-induced hand-foot syndrome in colorectal cancer patients receiving adjuvant chemotherapy with capecitabine plus oxaliplatin (T-CRACC study)

Yohei Iimura, Naoki Furukawa, Masaaki Ishibashi, Yuka Ahiko, Taro Tanabe, Susumu Aikou, Dai Shida, Masanori Nojima, Seiichiro Kuroda, Narikazu Boku

BMC Gastroenterol. 2022; 22: 341. Published online 2022 Jul 14. doi: 10.1186/s12876-022-02411-w

PMCID:: PMC9284769

Abstract Article PDF–1005K

Select item 927331619.

Development of a New Tool to Assess the Quality of Life of Patients with Hand–Foot Syndrome Receiving Capecitabine-Based Therapy: A Pilot Study

Prathepa Jagdish, Navdeep Kaur, Akhil Kapoor, Sarika Mandavkar, Anant Ramaswamy, Vikas Ostwal

South Asian J Cancer. 2022 Jan; 11(1): 19–23. Published online 2022 Jul 11. doi: 10.1055/s-0041-1735957

PMCID:: PMC9273316

Abstract Article PDF–583K

Select item 913643420.

Analysis of drug-induced hand–foot syndrome using a spontaneous reporting system database

Yu Yoshida, Sayaka Sasaoka, Mizuki Tanaka, Kiyoka Matsumoto, Misaki Inoue, Riko Satake, Kazuyo Shimada, Ririka Mukai, Takaaki Suzuki, Mari Iwata, Fumiya Goto, Takayuki Mori, Koki Mori, Tomoaki Yoshimura, Mitsuhiro Nakamura

Ther Adv Drug Saf. 2022; 13: 20420986221101963. Published online 2022 May 24. doi: 10.1177/20420986221101963